Optimization of Colon Specific Drug Delivery System for Ornidazole using modified gum
Abstract
The present study aimed to optimize a colon-specific formulation of ornidazole for the treatment of Crohn's disease and intestinal amoebiasis. Firstly carboxymethyl xanthan gum was prepared from xanthan gum reacting with monochloroacetic acid in alkaline conditions using the Williamson synthesis method. Fourier transform infrared spectrophotometer (FTIR) spectroscopy confirmed the formation of carboxymethyl xanthan gum. The differential scanning calorimetry (DSC) revealed the crystalline nature of carboxymethyl xanthan gum. A 32 full factorial design was used for optimization. The independent variables employed were the amount of Carboxymethyl Xanthan gum and the amount of hydroxy propyl methyl cellulose (HPMC), each at three levels. Drug release studies were carried out in various media [pH 1.2, 7.4, and 6.8]. The optimized formulation consisting of Carboxymethyl Xanthan gum (66 %) and HPMC (22%) released a small fraction of drug at pH 1.2 and pH 7.4, whereas significant drug release was observed at pH 6.8. The results of the study established Carboxymethyl Xanthan gum compression coated tablet to be a promising system for the colon-specific delivery of ornidazole to treat active Crohn's disease and intestinal amoebiasis.
Keywords:
Ornidazole, Carboxymethyl xanthan gum, Colon, Compression coating, HPMC.DOI
https://doi.org/10.25004/IJPSDR.2021.130210References
Chourasia MK, Jain SK. Design and development of multiparticulate system for targeted drug delivery to colon. Drug Deliv.2004;11:201– 207.
Philip AK, Philip B. Colon targeted drug delivery systems: a review on primary and novel approaches. Oman Med. J.2010;25:79–87.
Prajapati VD, Jani GK, Moradiya NG, Randeria NP. Pharmaceutical applications of various natural gums, mucilages and their modified forms. Carbohydrate Polymers. 2013;92:1685– 1699.
Vemula SK. A novel approach to flurbiprofen pulsatile colonic release: Formulation and pharmacokinetics of double compression coated mini tablets. AAPS Pharm.Sci. Tech.2015;16(6):1465-1473.
Maity S, Biswanath S. Ca-carboxymethyl xanthan gum mini-matrices: Swelling, erosion and their impact on drug release mechanism. Int.J.of Biological Macromolecules.2014;68:78–85.
Sinem YH, Zeynep AY, Mine O. Bioavailability file : Ornidazole. FABAD J. Pharm. Sci. 2004;29:133-144.
Singh P, Mittal R, Sharma GC, Singh S, Singh A. Ornidazole: Comprehensive profile. Profiles of drug substances excipients, and related methodology.2003;30:123-184.
Asghar LFA, Chure CB, Chandran S. Colon specific delivery of indomethacin: Effect of incorporating pH sensitive polymers in xanthan gum matrix bases. AAPS Pharm.Sci.Tech. 2009;10:418-429.
Yehia SA, Elshafeey AH, Sayed I, Shehata AH. Optimization of budesonide compression coated tablets for colonic delivery.AAPS Pharma.sci.Tech.2009;10:147-157.
Sanka K, Bandari S, Jukanti R, Veerareddy PR. Colon-specific microparticles of piroxicam: Formulation and optimization using 32 f actorial d esign. J o f D ispersion S ci. a nd Tech. 2 011;32:1396– 1403.
Dev RK, Bali V, Pathak K. Novel microbially triggered colon specific delivery system of 5-Fluorouracil:Statistical optimization, in vitro, in vivo, cytotoxic and stability assessment. International Journal of Pharmaceutics. 2011;411:142–151.
Published
Abstract Display: 567 
PDF Downloads: 436 
